Company
Memory loss and confusion are often the first signs that a loved one has dementia – struggling to find the right words, forgetting an important appointment, or a trip to the shops that takes much longer than normal. However, behavioural changes that typically occur in the mid- stages of the disease can prove the most challenging for people providing care. Milbotix founder Zeke shares a personal story about his great-grandmother, Kath.
“Kath was a gentle and sociable person with a life-long passion for jazz music. However, several years after her dementia diagnosis, she became prone to bouts of aggression which placed tremendous strain on my family.”
Company
Memory loss and confusion are often the first signs that a loved one has dementia – struggling to find the right words, forgetting an important appointment, or a trip to the shops that takes much longer than normal. However, behavioural changes that typically occur in the mid- stages of the disease can prove the most challenging for people providing care. Milbotix founder Zeke shares a personal story about his great-grandmother, Kath.
“Kath was a gentle and sociable person with a life-long passion for jazz music. However, several years after her dementia diagnosis, she became prone to bouts of aggression which placed tremendous strain on my family.”
Story
Zeke spent a couple of years volunteering at a care home and came to realise that Kath was not alone in experiencing agitation. Agitated symptoms such as aggression, irritability and resistance to care are highly prevalent in care homes and a significant source of burden for care workers. Zeke embarked on a PhD in Bristol, UK to investigate whether wearable technologies and robotics could help to reduce distress and agitation. During the research, he met Milbotix co-founders Jacqui and Iveta.
Mission
Milbotix was founded to improve access to digital technologies for people with unmet needs related to a health condition. Consistent with this aim, we have pledged to donate 10% of our profits to charitable causes including research into dementia.
Milbotix is funded by
Milbotix awards
